Many premature infants experience respiratory failure and receive supplemental oxygen for prolonged periods. While this therapy is crucial for their survival, it can be associated with complications such as retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), and central nervous system damage. In recent years, to minimize these complications clinicians have targeted progressively lower arterial oxygen saturation (SpO2) levels in these infants. This occurred despite little evidence for the efficacy and safety of this approach. Several randomized controlled trials have been conducted to test if targeting oxygen saturations in the lower (85%-89%) vs the upper (91%-95%) part of the recommended range confer advantages in regard to neurodevelopmental outcome and severe ROP in extremely premature infants.1
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 4
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.